Skip to content
Disclosery

EXANE DERIVATIVES: MCD position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on MCD, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 7,508 MCD shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 7,508 shares
    Change vs previous 13F -1,359 shares

    1.06% of the 13F portfolio, value $1,853,166.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 8,867 shares
    Change vs previous 13F -949 shares

    0.62% of the 13F portfolio, value $2,192,467.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 9,816 shares
    Change vs previous 13F -2,267 shares

    0.64% of the 13F portfolio, value $2,631,244.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 12,083 shares
    Change vs previous 13F +2,714 shares

    0.73% of the 13F portfolio, value $2,913,188.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 9,369 shares
    Change vs previous 13F +1,876 shares

    0.52% of the 13F portfolio, value $2,212,608.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 7,493 shares
    Change vs previous 13F -145 shares

    0.51% of the 13F portfolio, value $1,679,379.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 7,638 shares
    Change vs previous 13F +1,281 shares

    0.5% of the 13F portfolio, value $1,638,859.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 6,357 shares
    Change vs previous 13F not available

    0.45% of the 13F portfolio, value $1,395,240.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).